Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: Am J Cardiol. 2018 Mar 13;121(12):1552–1557. doi: 10.1016/j.amjcard.2018.02.042

Table 1.

Demographics of the echocardiogram population.

Characteristic Normal (n=4587) Stage 1 DD (n=1676) p-value
Ages (years)
40–45 1449 (32%) 257 (15%) <.00011
45–50 1605 (35.0%) 475 (28%)
50–55 1533 (33%) 944 (57%)
Men 1920 (42%) 769 (46%) 0.0091
Women 2663 (58%) 907 (54%)
White 3617 (79%) 1261 (75%) <.00011
Black 635 (14%) 306 (18%)
Unknown 335 (7%) 109 (7%)
Duration prior to TTE (years)2 2.9 (0.6–5.5) 2.6 (0.4–5.3)
Duration post TTE (years)2 2.7 (0.1–7.7) 2.4 (0.1–7.6)
Systolic blood pressure (mmHg)3 123 ± 17 130 ± 20 <0.00014
Diastolic blood pressure (mmHg)3 75 ± 11 79 ± 13 <0.00014
Heart rate (beats per minute)3 79 ± 16 85 ± 17 <0.00014
Body mass index (kg/m2)3 30.4 ± 7.9 33.5 ± 8.4 <0.00014
Creatinine level (mg/dl)3 0.85 (0.70–1.03) 0.92 (0.77–1.16) <0.00014
Serum glucose (mg/dl)3 97 (87–114) 106 (92–136) <0.00014

Notes:

1

P-values are from a chi-square test evaluating the distributions across age, gender and racial groups among individuals with normal versus stage 1 DD.

2

Median (interquartile range) number of years of patient data available prior to or after the TTE.

3

Values are mean (standard deviation) except for creatinine and glucose which are median (interquartile range).

4

P-value from a linear regression model adjusting for age, gender, self-reported race and setting. Log-transformed values were analyzed for creatinine and glucose.

HHS Vulnerability Disclosure